no statement of use filed
on 28 Sep 2020
Last Applicant/ Owned by
3 - 1121 Walker's Line
Burlington, Ontario
CA
L7N2G4
Serial Number
88021002 filed on 29th Jun 2018
Registration Number
N/A
Correspondent Address
Todd A. Van Thomme
Filing Basis
1. intent to use current
Disclaimer
NO DATA
Orally dissolvable films containing nutraceuticals, namely, biotin, folic acid, resveratrol, DHEA, NAD, curcumin; orally dissolvable films containing, vitamins, caffeine, melatonin, and herbal supplements for general health and well-being, dietary supplements for general health and well-being, nicotine and nicotine-polymer complexes; orally dissolvable films containing non-prescription pharmaceuti Read More
Orally dissolvable films containing nutraceuticals, namely, biotin, folic acid, resveratrol, DHEA, NAD, curcumin; orally dissolvable films containing, vitamins, caffeine, melatonin, and herbal supplements for general health and well-being, dietary supplements for general health and well-being, nicotine and nicotine-polymer complexes; orally dissolvable films containing non-prescription pharmaceutical preparations sold over-the-counter for the relief of pain, cough, cold, flu, allergy symptoms, cardiac health, nicotine smoking cessation, anti-gas for stomach bloating, anemia, and to promote wound healing; orally dissolvable films containing prescription pharmaceutical preparations indicated for the relief of nausea, vomiting, hyperglycemia, diabetes, erectile dysfunction, anti-anxiety, anti-depressant, migraine headache pain, anemia, cardiac health, angina, hypertension, and to reverse and prevent opioid overdose; orally dissolvable films containing human vaccine and human biologic medications which function as biologic response modifiers in the human immune system for the treatment and prevention of influenza, auto-immune disease syndrome (AIDS), HIV infections, inflammatory bowel disease, Crohn's Disease, Ulcerative Colitis, rheumatoid arthritis, diabetes, insulinemia, psoriasis, herpes, HPV prevention, polio, tuberculosis, hepatitis, diphtheria, typhoid, meningitis, multiple sclerosis, lupus, Varicella viral infections (chicken pox), West Nile Virus infections, H1N1 flu infections, cancer, and age-related Macular Degeneration; none of the foregoing comprised of Cannabis sativa based ingredients
Consulting in the healthcare field regarding orally dissolvable films containing nutraceuticals, namely, biotin, folic acid, resveratrol, DHEA, NAD, curcumin; consulting in the healthcare field related to orally dissolvable films containing, vitamins, caffeine, melatonin, herbal supplements for general health and well-being, dietary supplements for general health and well-being, nicotine and nicotine-polymer complexes; consulting in the healthcare field related to orally dissolvable films containing non-prescription pharmaceutical preparations sold over-the-counter for the relief of pain, cough, cold, flu, allergy symptoms, cardiac health, nicotine smoking cessation, anti-gas for stomach bloating, anemia, and to promote wound healing; consulting in the healthcare field related to orally dissolvable films containing prescription pharmaceutical preparations indicated for the relief of nausea, vomiting, hyperglycemia, diabetes, erectile dysfunction, anti-anxiety, anti-depressant, migraine headache pain, anemia, cardiac health, angina, hypertension, and to reverse and prevent opioid overdose; consulting in the healthcare field related to orally dissolvable films containing human vaccine and human biologic medications which function as biologic response modifiers in the human immune system for the treatment and prevention of influenza, auto-immune disease syndrome (AIDS), HIV infections, inflammatory bowel disease, Crohn's Disease, Ulcerative Colitis, rheumatoid arthritis, diabetes, insulinemia, psoriasis, herpes, HPV prevention, polio, tuberculosis, hepatitis, diphtheria, typhoid, meningitis, multiple sclerosis, lupus, Varicella viral infections (chicken pox), West Nile Virus infections, H1N1 flu infections, cancer, and age-related Macular Degeneration
No 88021002
No Service Mark
No 3009575-2012
No
No
No
No
No
No
Yes
No
Status Date | Action Taken |
---|---|
28th Sep 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
28th Sep 2020 | ABANDONMENT - NO USE STATEMENT FILED |
25th Feb 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
31st Dec 2019 | PUBLISHED FOR OPPOSITION |
31st Dec 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
11th Dec 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
22nd Nov 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
15th Nov 2019 | EXAMINER'S AMENDMENT ENTERED |
15th Nov 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
15th Nov 2019 | EXAMINERS AMENDMENT -WRITTEN |